Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 23 February 2018

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Genes influence susceptibility and severity of Crohn's

The IBD5 locus influences susceptibility, progression, and need for surgery in Crohn's disease, and organic cation transporter genes 1/2 variants are not independent of the IBD5 haplotype, reports the latest issue of Gastroenterology.

News image

fiogf49gjkf04

Polymorphisms in the organic cation transporter genes 1 and 2 represent disease-causing mutations within the IBD5 locus (chromosome 5q31).

Dr Colin Noble and colleagues investigated associations with disease susceptibility, phenotype, and evidence for epistasis with CARD15.

The research team assessed a total of 679 patients, of which 374 had Crohn's disease, 305 had ulcerative colitis and 294 were health controls.

Genotyping for single nucleotide polymorphisms IGR2096, IGR2198, and IGR2230, organic cation transporter genes 1 and 2 variants was performed using the TaqMan system.

The team found that the IBD5 organic cation transporter genes 1 and 2 polymorphisms were in strong linkage disequilibrium.

The IGR2198 variant allele frequency was associated with Crohn's disease
Gastroenterology

The IGR2198 variant allele frequency and homozygosity were associated with Crohn's disease compared with healthy controls.

Variant allelic frequency of organic cation transporter genes 1 and 2 polymorphism was associated with Crohn's.

The team also observed that homozygosity for the organic cation transporter genes 1- and 2-variants haplotype were associated with Crohn's.

The team noted that IGR2198 homozygosity and organic cation transporter genes 1/2 variatns homozygosity were associated with stricturing/penetrating disease on follow-up.

Using univariate analysis, the team found that disease progression was associated with IGR2198 and organic cation transporter genes variants homozygosity.

The IGR2198 and organic cation transporter genes homozygosity were associated with the need for surgery on multivariate analysis.

In the absence of the IBD5 risk haplotype, no association of organic cation transporter genes 1/2 variants with Crohn's disease was detected.

No associations were seen with ulcerative colitis.

Dr Noble and team conclude, “The IBD5 locus influences susceptibility, progression, and need for surgery in Crohn's disease.”

“The contribution of organic cation transporter genes 1/2 variants is not independent of the IBD5 haplotype.”

“A causative role for these genes remains plausible but is not yet proven.”

“Further genetic, functional, and expression data are now required.”

Gastroenterol 2005: 129(6): 1854-64
05 January 2006

Go to top of page Email this page Email this page to a colleague

 23 February 2018 
MRI and NAFLD
 23 February 2018 
Heavy metals on a gluten-free diet
 23 February 2018 
Patients on antithrombotic agents undergoing emergency and elective endoscopy
 22 February 2018 
Autophagy enhancers
 22 February 2018 
Outcomes with Crohn’s after infliximab withdrawal
 22 February 2018 
Elderly onset of IBD

 21 February 2018 
Adalimumab and infliximab in biologic-naïve Crohn's
 21 February 2018 
Cystic fibrosis and colorectal cancer
 21 February 2018 
Management of hemorrhoids in the USA
 20 February 2018 
Treatment algorithm for polyp cancers
 20 February 2018 
Predictors of postoperative infection in Crohn's
 20 February 2018 
Complications and surveillance colonoscopies
 19 February 2018 
Screening colonoscopy in the right and left colon
 19 February 2018 
NAFLD prevalence in the USA
 19 February 2018 
Fructans in children with IBS

 16 February 2018 
Undetected celiac in the elderly
 16 February 2018 
Inflammatory bowel diseases are global diseases
 16 February 2018 
Fructans induce non-celiac gluten sensitivity
 15 February 2018 
NSAIDS and GI damage
 15 February 2018 
Oral direct-acting antiviral treatment for Hep C virus genotype 1
 15 February 2018 
Primary vs secondary surgery for the presence of lymph node metastasis
 14 February 2018 
Predicting adenoma detection rate
 14 February 2018 
Normal bowel frequency characterization in the USA 
 13 February 2018 
Personalising treatment options for IBS
 13 February 2018 
Prebiotics improve endothelial dysfunction
 13 February 2018 
Diagnostic criteria for a Rome IV functional gastrointestinal disorders
 12 February 2018 
Visceral hypersensitivity and functional GI disorders
 12 February 2018 
Depression and aggressive IBD
 12 February 2018 
Variability in interpretation of endoscopic findings impacts patient management
 09 February 2018 
Treatment of choice for anastomotic stricture in IBD
 09 February 2018 
PRO measurement information system 
 09 February 2018 
Overall disease severity indices for IBD
 08 February 2018 
Prediction of endoscopically active disease

 08 February 2018 
Steroid-refractory acute severe ulcerative colitis
 08 February 2018 
Decision aid used by IBD patients
 07 February 2018 
Ursodeoxycholic acid combined with bezafibrate for itching
 07 February 2018 
Change in microbiome in gastritis vs gastric carcinoma
 07 February 2018 
Colorectal cancer and primary sclerosing cholangitis-IBD
 06 February 2018 
Risk of death after liver transplantation
 06 February 2018 
Crohn’s disease vs refractory pouchitis
 06 February 2018 
Support for functional dyspepsia symptom diary
 05 February 2018 
Helicobacter spp influence on GI tract 
 05 February 2018 
No link found between severe reflux and all-cause mortality 
 05 February 2018 
Psychological distress in PPI non-responders
 02 February 2018 
Assessing psychosexual impact of IBD
 02 February 2018 
Decrease in overall mortality with cholera vaccination
 02 February 2018 
Diagnostic performance of fecal immunochemical tests
 01 February 2018 
Screening frequency with family histories of colorectal cancer
 01 February 2018 
IBD and sport participation
 01 February 2018 
Life with a stoma 
 31 January 2018 
Aprepitant and gastroparesis 
 31 January 2018 
Anesthesia risk in colonoscopy
 31 January 2018 
GED-0301 for Crohn's Disease
 30 January 2018 
Intestinal dysbiosis and allergic diseases in infants
 30 January 2018 
Fructans and IBS symptoms in children
 29 January 2018 
Dosing calculator for therapy optimization in IBD
 29 January 2018 
Glecaprevir–pibrentasvir for in HCV
 29 January 2018 
Food allergen injections in eosinophilic esophagitis
 29 January 2018 
Reliability of the IBD index
 26 January 2018 
Tofacitinib vs biological therapies for ulcerative colitis

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2018 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us